References
- OzanneBNelsonJCousineauJThreshold for toxicity from hyperammonemia in critically ill childrenJ Hepatol201256112312821703182
- HakvoortTBHeYKulikWPivotal role of glutamine synthetase in ammonia detoxificationHepatology201765128129327641632
- AuronABrophyPDHyperammonemia in review: pathophysiology, diagnosis, and treatmentPediatr Nephrol201227220722221431427
- WijdicksEFHepatic encephalopathyN Engl J Med2016375171660167027783916
- PaprockaJJamrozEHyperammonemia in children: on the crossroad of different disordersNeurologist201218526126522931730
- Ducharme-CrevierLDupont-ThibodeauGLortieAMarandaBTaskerRJouvetPMetabolic encephalopathies in childrenNicholsDRogers Textbook of Pediatric Intensive CarePhiladelphia, PALippincott, Williams & Wilkins201610531065
- BroomfieldAGrunewaldSHow to use serum ammoniaArch Dis Child Educ Pract Ed2012972727722101094
- Urea Cycle Disorders Conference groupConsensus statement from a conference for the management of patients with urea cycle disordersJ Pediatr20011381 SupplS1S511148543
- MarandaBCousineauJAllardPLambertMFalse positives in plasma ammonia measurement and their clinical impact in a pediatric populationClin Biochem200740853153517408610
- GunzACChoongKPotterMMillerEMagnetic resonance imaging findings and neurodevelopmental outcomes in neonates with urea-cycle defectsInt Med Case Rep J20136414823983495
- ZhangXDZhangLJWuSYLuGMMultimodality magnetic resonance imaging in hepatic encephalopathy: an updateWorld J Gastroenterol20142032112621127225170210
- O’Donnell-LuriaAHLinAPMerugumalaSKBrain MRS glutamine as a biomarker to guide therapy of hyperammonemic comaMol Genet Metab2017121191528408159
- SuPHChenJYChenYJNiuDMHsuJHLeeICElectroencephalography and transcranial Doppler ultrasonography in neonatal citrullinemiaJ Formos Med Assoc20141131185786125443352
- BernalWWendonJAcute liver failureN Engl J Med2013369262525253424369077
- SundaramSSAlonsoEMNarkewiczMRZhangSSquiresRHPediatric Acute Liver Failure Study GroupCharacterization and outcomes of young infants with acute liver failureJ Pediatr20111595813818.e121621221
- CaldovicLAbdikarimINarainSTuchmanMMorizonoHGenotype-phenotype correlations in ornithine transcarbamylase deficiency: a mutation updateJ Genet Genomics201542518119426059767
- SpodenkiewiczMDiez-FernandezCRufenachtVGemperle-BritschgiCHaberleJMinireview on glutamine synthetase deficiency, an ultra-rare inborn error of amino acid biosynthesisBiology (Basel)201654
- Ah MewNCaldovicLN-Acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatmentAppl Clin Genet201141273523776373
- AliEZKhalidMKYunusZMCarbamoylphosphate synthetase 1 (CPS1) deficiency: clinical, biochemical, and molecular characterization in Malaysian patientsEur J Pediatr2016175333934626440671
- NagamaniSCErezALeeBArgininosuccinate lyase deficiencyGenet Med201214550150722241104
- BaruteauJJamesonEMorrisAAExpanding the phenotype in argininosuccinic aciduria: need for new therapiesJ Inherit Metab Dis201740335736828251416
- HaberleJClinical and biochemical aspects of primary and secondary hyperammonemic disordersArch Biochem Biophys2013536210110823628343
- ImamuraYKobayashiKShibatouTEffectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the diseaseHepatol Res2003261687212787807
- KhalessiNKhosraviNMirjafariMAfsharkhasLPlasma ammonia levels in newborns with asphyxiaIran J Child Neurol20161014246
- GlasgowJFMiddletonBReye syndrome – insights on causation and prognosisArch Dis Child200185535135311668090
- KumarRShalimarSharmaHPersistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failureClin Gastroenterol Hepatol201210892593122521861
- HaberleJBoddaertNBurlinaASuggested guidelines for the diagnosis and management of urea cycle disordersOrphanet J Rare Dis201273222642880
- HaberleJClinical practice: the management of hyperammonemiaEur J Pediatr20111701213421165747
- MatooriSLerouxJCRecent advances in the treatment of hyperammonemiaAdv Drug Deliv Rev201590556825895618
- KajiKTakayaHSaikawaSRifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversityWorld J Gastroenterol201723478355836629307995
- JawaroTYangADixitDBridgemanMBManagement of hepatic encephalopathy: a primerAnn Pharmacother201650756957727126547
- MisslerJZwingmannCL-Carnitine in hyperammonemia and hepatic encephalopathyTanasescuRMiscellanea on Encephalopathies – A Second LookShanghaiIn Tech2012365390
- CalligarisLVidoniABrunoIVidoniMBarbiEEfficacy of clonidine in hyperammonemia induced hyperexcitability syndromePaediatr Anaesth201323220220423289776
- PiccaSDionisi-ViciCBartuliAShort-term survival of hyperammonemic neonates treated with dialysisPediatr Nephrol201530583984725185886
- JouvetPSchaeferFDialytic therapy of inborn errors of metabolismWaradyBSchaeferFAlexanderSPediatric Dialysis2nd edBostonSpringer Verlag2012765774
- LiottaEMRomanovaALLizzaBDOsmotic shifts, cerebral edema, and neurologic deterioration in severe hepatic encephalopathyCrit Care Med201846228028929341965
- JalanROlde DaminkSWDeutzNEHayesPCLeeAModerate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertensionGastroenterology200412751338134615521003
- JalanRRoseCHypothermia in acute liver failureMetab Brain Dis2004193–421522115554417
- Lichter-KoneckiUNadkarniVMoudgilAFeasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemiasMol Genet Metab2013109435435923791307
- DaniottiMla MarcaGFioriniPFilippiLNew developments in the treatment of hyperammonemia: emerging use of carglumic acidInt J Gen Med20114212821403788
- KuchlerGRabierDPoggi-TravertFTherapeutic use of carbamylglutamate in the case of carbamoyl-phosphate synthetase deficiencyJ Inherit Metab Dis19961922202228739970
- ValayannopoulosVBaruteauJDelgadoMBCarglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational studyOrphanet J Rare Dis2016113227030250
- KasapkaraCSEzguFSOkurITumerLBiberogluGHasanogluAN-Carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemiaEur J Pediatr2011170679980121207059
- ReyesDBarreraFIs flumazenil an alternative for the treatment of hepatic encephalopathy?Medwave2017179e711329286356
- CunninghamSCKokCYSpinoulasACarpenterKHAlexanderIEAAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemiaGene Ther201320121184118724108150
- CunninghamSCKokCYDaneAPInduction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene deliveryMol Ther201119585485921386824
- CunninghamSCSiewSMHallwirthCVModeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery systemHepatology201562241742826011400
- van WenumMAdamAAHakvoortTBSelecting cells for bioartificial liver devices and the importance of a 3D culture environment: a functional comparison between the HepaRG and C3A cell linesInt J Biol Sci201612896497827489500